Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Prachi Srivastava is active.

Publication


Featured researches published by Prachi Srivastava.


Annals of Ophthalmology | 2004

Impaired anti-oxidant defense mechanism in central eales disease

Sandeep Saxena; Dipak Kumar; Vinay K. Khanna; Prachi Srivastava; Prahlad K. Seth

A tertiary care center-based, case-control study evaluated the status of oxidative stress, enzymes involved in the antioxidant defense and membrane fluidity in platelets of 6 cases with central Eales disease and 5 healthy controls. Significant differences were observed between malonaldialdehyde, superoxide dismutase and catalase levels in the cases and controls. Enhanced oxidative stress, is consistent with an emerging view that antioxidant defenses decline in association with the disease process.


Annals of Ophthalmology | 2003

Retinal neovascularization in eales disease

Sandeep Saxena; D. Kumar; Amit Maitreya; Prachi Srivastava; Vinay K. Khanna; Rajiv Nath; Prahlad K. Seth

A study was undertaken, using fluorescein angiography, to correlate the area of capillary nonperfusion (CNP) with the occurrence of retinal neovascularization in 20 cases of Eales disease. Neovascularization elsewhere and neovascularization of the disc were found in eyes with greater than 20 and 60 disc areas CNP, respectively. The role of lipid peroxides in neovascularization was also studied biochemically. A significant increase in platelet malondialdehyde levels was observed in cases with neovascularization.


International Journal of Computer Applications | 2015

Choke Point Analysis with Subtractive Proteomic Approach for Insilico Identification of Potential Drug Targets in Shigella Dysenteriae

Manmohan Pandey; Anshul Tiwari; Shalini Maurya; Dipika Singh; Prachi Srivastava

Shigellosis is an endemic disease prevalent in developing and poor countries due to fecal-oral transmission resulting a significant morbidity and mortality rate. Emergence of multidrug resistant (MDR) in Shigella sp. reveals the inefficacy towards the first line antibiotics like quinolones, cotrimoxazole and ampicillin against it. There is continuous need to monitor the characteristics and antibiotic resistance patterns of this pathogen regarding the identification of new potential therapeutic drug targets. Availability of complete protein of different Shigella species viz flexneri, body, dysentery and son has made it possible to carry out the Insilico analysis of its protein for the identification of potential vaccine and drug targets. Subtractive proteomics approach is being used to mine the list of proteins present in different Shigella species which are non-homologous to human and essential for the survival of the pathogen. The metabolic chokepoint analysis also enriches the list of essential protein and adds those proteins in the list which are uniquely found in pathogenic pathway, catalyzed by single enzyme and involved in multi pathways. Screening of essential proteins against human gut flora and approved drug targets revealed the targets which are non-homologous to human gut flora and homologous to the approved drug targets. Broad spectrum drug targets screening revealed a list of highly conserved proteins of various pathogens including different Shigella species. Probably the drug developed against these targets may be useful in treating multiple diseases or diseases which results due to co-infection of different pathogens. Subcellular localization prediction revealed a list protein, which could be potential vaccine targets in different Shigella species. Virtual screening against these identified targets might be useful in the discovery of novel Drug against MDR Shigella species.


Asia-Pacific journal of ophthalmology | 2014

Virtual Screening of Natural and Synthetic Ligands Against Diabetic Retinopathy by Molecular Interaction With Angiopoietin-2.

Prachi Srivastava; Anshul Tiwari; Trivedi Ac; Thakur; Pant Ab; Sandeep Saxena

PurposeDiabetic retinopathy (DR) is the most common diabetic eye disease and a leading cause of blindness. The role of angiopoietin-2 a tyrosine kinase receptor is well-reported in angiogenesis during the onset of the disease. The purpose of this study is to screen out more potential herbal molecules which can evidently be used as a better, natural and safe herbal drug against this disease. DesignIn silico virtual screening and molecular interaction studies were performed. MethodsThe current course of work focused on molecular interactions on angiopoietin-2 protein with selected natural ligands, namely allicin, ajoene, D-pinitol and salacinol, along with synthetic ones like nateglinide, biguanide, tolbutamide and tolazamide. There was an attempt to carry out the virtual comparative study between natural and synthetic ligands. Proceeding toward this approach, docking of all molecules was performed using the Autodock 4.2 program. ResultsInference of this interaction study is that D-pinitol, which is the herbal extract of Glycine max, shows a very reliable docking pattern as compared with the synthetic ligand tolazamide. Although the binding energy of a synthetic ligand is lower compared to that of the natural ones, the binding energy of synthetic and natural ligands are at an approximate level. The lower the binding energy, the better the ligand molecular interaction. ConclusionsOur findings suggest that D-pinitol, the natural, safe ligand, can be used in the treatment of diabetic retinopathy with few or no side effects after estimating and calculating proper doses using in vitro approaches.


Asia-Pacific journal of ophthalmology | 2013

Bioinformatics in Retina.

Anshul Tiwari; Sandeep Saxena; Prachi Srivastava

Abstract Bioinformatics, a word coined for the applications of computer science in biology, is now promising as a major constituent in modern biology and biomedical research. Bioinformatics plays an important role for the integration of broad disciplines of biology to understand the complex mechanisms of the cell. Bioinformatics also aids the way in which biomedical investigators use the information in their testing. Development and implementation of this novel field enable efficient access and management of different types of biological information including those at the genomic, proteomic, and metabolomic level to understand about disease mechanisms and identify new molecular targets for drug discovery. Bioinformatics has expanded its wings in exploring out different important contributions in relation with medical sciences such as neurology, parasitology, hematology, and pathology including ophthalmology. Many bioinformatics-oriented studies have contributed a lot in ophthalmology and given birth to new avenues of occuloinformatics, hence, a new coined term, occuloinformatics: a new approach of research and diagnostics related to ocular disorders with significant inputs of bioinformatics. In this current review, we tried to focus on current avenues and significant contributions of bioinformatics with special reference to retinal disorders.


Annals of Ophthalmology | 2001

Enhanced oxidative stress in eales disease

Sandeep Saxena; Vinay K. Khanna; Dipak Kumar; Prachi Srivastava; Prahlad K. Seth


Journal of Ocular Pharmacology and Therapeutics | 2010

Antioxidant supplementation improves platelet membrane fluidity in idiopathic retinal periphlebitis (Eales' disease).

Sandeep Saxena; Prachi Srivastava; Vinay K. Khanna


Current Topics in Medicinal Chemistry | 2017

Critical Role of Computer Simulations in Drug Discovery and Development

Prachi Srivastava; Anshul Tiwari


International journal of neurology | 2016

Implication of Fyn C-Kinase as a Common Therapeutic Target for Alzheimer Disease and Its Inhibition Using Natural Compounds

Prachi Srivastava; Shreya Srivastava; Anshul Tiwari


Current Topics in Medicinal Chemistry | 2015

A New Insight of Herbal Promises Against Ocular Disorders: An Occuloinformatics Approach

Prachi Srivastava; Anshul Tiwari

Collaboration


Dive into the Prachi Srivastava's collaboration.

Top Co-Authors

Avatar

Anshul Tiwari

King George's Medical University

View shared research outputs
Top Co-Authors

Avatar

Sandeep Saxena

King George's Medical University

View shared research outputs
Top Co-Authors

Avatar

Vinay K. Khanna

Indian Institute of Toxicology Research

View shared research outputs
Top Co-Authors

Avatar

Prahlad K. Seth

Indian Institute of Toxicology Research

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Aditya Bhushan Pant

Indian Institute of Toxicology Research

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

D. Kumar

Indian Institute of Toxicology Research

View shared research outputs
Researchain Logo
Decentralizing Knowledge